TokenPost·
Vir Biotechnology Narrows Third-Quarter Net Loss to $96.3 Million
The company’s loss per share was $0.57, compared with $1.17 a year earlier. Cash, cash equivalents and investments totaled about $901.3 million at Sept. 30.
More news
- TokenPostEther Rises 1.46% in an Hour to $2,241 Despite Daily Losses
- TokenPostNVIDIA Uses AI Agents to Trace Failures Across DGX SuperPOD Clusters
- TokenPostSeaport Entertainment Group Revenue Falls 27.4% in Q3 as Adjusted Loss Narrows
- TokenPostSouth Korea’s KOSPI Triggers 20-Minute Halt After 8% Drop
- TokenPostATN International Posts $1.09 Q3 EPS as Revenue Stays Flat
- TokenPostFive Companies Were Scheduled to Report Earnings Before Thursday’s Open